Recent advances in recurrent hepatocellular carcinoma therapy

Hepatocellular carcinoma (HCC) is the most prevalent form of primary liver cancer, accounting for 75%-85% of cases. Although treatments are given to cure early-stage HCC, up to 50%-70% of individuals may experience a relapse of the illness in the liver after 5 years. Research on the fundamental trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Yu-Xue, Ning, Qi-Qi, Yang, Peng-Xiang, Guan, Yuan-Yue, Liu, Peng-Xiang, Liu, Meng-Lu, Qiao, Lu-Xin, Guo, Xiang-Hua, Yang, Tong-Wang, Chen, De-Xi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10190692/
https://www.ncbi.nlm.nih.gov/pubmed/37206651
http://dx.doi.org/10.4254/wjh.v15.i4.460

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10190692/
https://www.ncbi.nlm.nih.gov/pubmed/37206651
http://dx.doi.org/10.4254/wjh.v15.i4.460

Ejemplares similares